Endometrial cancer due to busulfan therapy. Report of two cases.
Two patients with CML who developed endometrial cancer following 2 years of busulfan treatment are reported. The possibility of a causal relationship between the cytotoxic drug and the development of this malignancy is discussed.
D000230:Adenocarcinoma / Q000139:chemically induced; D002066:Busulfan / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000139:chemically induced; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000139:chemically induced*
D002066:Busulfan